Education
About Us
Working with TipRanks
Follow Us
TACN - ETF AI Analysis
Top Page
T. Rowe Price Active Core International Equity ETF (TACN)
Rating:66Neutral
Price Target:―
Positive Factors
Global Diversification
The ETF has exposure to a wide range of countries, reducing the risk of being tied to a single economy.
Low Expense Ratio
The ETF charges no expense ratio, making it a cost-effective choice for investors.
Strong Sector Representation
The fund is well-diversified across multiple sectors, with significant exposure to stable industries like Financials and Health Care.
Negative Factors
Small Asset Base
The ETF has relatively low assets under management, which could limit liquidity and increase trading costs.
Moderate U.S. Exposure
The fund has limited exposure to the U.S. market, which could miss out on growth opportunities in the world's largest economy.
Concentration in Financials
The ETF has a heavy weighting in the Financial sector, which could increase vulnerability to sector-specific downturns.
TACN vs. SPDR S&P 500 ETF (SPY)
AUM18.00M
RegionDeveloped Markets
Expense Ratio0.00%
Beta0.25
IssuerT. Rowe Price
Inception DateN/A
Dividend YieldN/A
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume7,446
30 Day Avg. Volume4,649
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
30.41Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering483
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
TACN Summary
The T. Rowe Price Active Core International Equity ETF (TACN) is an actively managed fund that focuses on international stocks, offering exposure to companies across various industries and regions. It includes well-known names like ASML Holding and AstraZeneca, and invests heavily in sectors like financials and industrials. This ETF is ideal for investors looking to diversify their portfolio with global companies and potentially benefit from long-term growth opportunities. However, since it invests in international markets, its performance can be affected by global economic conditions and currency fluctuations.
How much will it cost me?The T. Rowe Price Active Core International Equity ETF (TACN) has an expense ratio of 0.0%, meaning you won’t pay any annual fees for every $1,000 invested. This is significantly lower than average, as most ETFs, especially actively managed ones like TACN, typically charge fees to cover management costs. This makes it an exceptionally cost-effective option for investors.
What would affect this ETF?The T. Rowe Price Active Core International Equity ETF (TACN) could benefit from economic growth in developed markets outside North America, particularly in sectors like financials and industrials, which make up a significant portion of its portfolio. However, it may face challenges from global economic slowdowns, regulatory changes in key regions, or currency fluctuations that could impact international investments. Additionally, sector-specific risks, such as volatility in energy or technology, could influence the ETF's performance.
TACN Top 10 Holdings
TACN leans heavily on Europe, with ASML acting as the fund’s main engine lately, riding strong demand for chip equipment and giving performance a solid lift. A trio of pharma giants—Roche, Novartis, and AstraZeneca—adds a defensive backbone, though AstraZeneca has been a bit mixed and occasionally loses steam. Big banks like HSBC and BBVA are also pulling their weight, benefiting from firm financial results. On the flip side, consumer staple Nestlé has been more of a quiet drag, keeping overall gains from running too far ahead.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 2.93% | $529.32K | €454.71B | 63.98% | 76 Outperform | |
| AstraZeneca | 1.66% | $301.02K | $319.11B | 29.06% | 80 Outperform | |
| Roche Holding AG | 1.58% | $286.64K | CHF287.83B | 46.49% | 73 Outperform | |
| Novartis AG | 1.41% | $254.69K | CHF238.17B | 30.71% | 80 Outperform | |
| Shell (UK) | 1.13% | $204.36K | £162.38B | 6.90% | 73 Outperform | |
| HSBC Holdings | 1.12% | $202.14K | £212.73B | 40.54% | 80 Outperform | |
| Nestlé SA | 1.05% | $190.83K | CHF201.28B | 12.20% | 71 Outperform | |
| LVMH Moet Hennessy Louis Vuitton | 0.95% | $171.79K | €255.60B | -26.71% | 78 Outperform | |
| Banco Bilbao Vizcaya Argentaria | 0.95% | $171.78K | €108.85B | 58.47% | 76 Outperform | |
| Siemens | 0.91% | $164.20K | €195.89B | 10.40% | 74 Outperform |
TACN Technical Analysis
Positive
―
Price Trends
Market Momentum
0.50
Negative
67.11
Neutral
82.96
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For TACN, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 27.16, equal to the 50-day MA of ―, and equal to the 200-day MA of ―, indicating a neutral trend. The MACD of 0.50 indicates Negative momentum. The RSI at 67.11 is Neutral, neither overbought nor oversold. The STOCH value of 82.96 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TACN.
TACN Peer Comparison
Comparison Results
Performance Comparison
TACN
T. Rowe Price Active Core International Equity ETF
27.84
2.54
10.04%
JIRE
JPMorgan International Research Enhanced Equity ETF
―
―
―
QUIZ
Zacks Quality International ETF
―
―
―
AIVI
WisdomTree International AI Enhanced Value Fund
―
―
―
PQNT
Pictet AI Enhanced International Equity ETF
―
―
―
IVSI
Applied Finance IVS International Large ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents